ArticlePloS one2026
Red blood cell distribution width to albumin ratio and systemic immune-inflammatory index as predictors of mortality in severe pneumonia: A retrospective cohort analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSevere pneumonia carries a high risk of mortality. There is a need for readily available prognostic biomarkers to improve risk stratification. This study evaluated the prognostic value of two novel composite indices, the red blood cell distribution width-to-albumin ratio (RAR) and the systemic immune-inflammation index (SII), in patients with severe pneumonia.
methodsThis retrospective cohort study extracted data from electronic medical records of 194 adult patients (age ≥ 18 years) with severe pneumonia (diagnosed per Chinese guidelines) admitted to Jinhua Hospital (January 2022 to December 2024). After screening 2,268 admissions, 194 patients with complete 24-hour data were classified into survivors (n = 147) and non-survivors (n = 47). Associations between RAR, SII, and in-hospital mortality were analyzed using multivariate logistic regression, receiver operating characteristic (ROC) curves, and Kaplan-Meier survival analysis.
resultsCompared with survivors, non-survivors had a significantly higher RAR (median: 0.44 vs. 0.37, p < 0.001) and SII (median: 2389 vs. 1870, p = 0.002). RAR was positively correlated with D-dimer (r = 0.254, p < 0.001), and negatively correlated with uric acid (UA) (r = -0.147, p = 0.042). SII was positively correlated with C-reactive protein (CRP) (r = 0.150, p = 0.037) and interleukin-6 (IL-6) (r = 0.188, p = 0.009). Advanced age (OR=1.042; 95%CI:1.004-1.082; p = 0.030), high RAR (OR=2.492; 95%CI:1.642-3.781; p < 0.001) and high SII (OR=1.575; 95%CI:1.074-2.309; p = 0.036) were independent risk factors for death in patients with severe pneumonia. The ROC of RAR and SII for predicting death in patients with severe pneumonia was 0.722 and 0.652, respectively. Patients with RAR < 0.43 had a higher cumulative survival than patients with RAR ≥ 0.43 (85.6% [119/139] vs. 50.9% [28/55]; HR = 4.987; 95%CI: 2.592-9.593; p < 0.001); Patients with SII < 2120 had a higher cumulative survival than patients with SII ≥ 2120 (86.9% [93/107] vs. 62.1% [54/87]; HR = 2.745; 95%CI: 1.531-4.924; p < 0.001).
conclusionsElevated RAR and SII are significantly associated with an increased risk of in-hospital death in severe pneumonia patients. These indices may therefore serve as useful, readily available, and inexpensive prognostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.